Emicizumab(ACE 910) is a bispecific monoclonal antibody that bridges activated factor IX and activated factor X to mimic the function of activated factor VIII. Emicizumab is used for the prevention and treatment of hemophilia A.
Purity:
98.10%
CAS Number:
[1610943-06-0]
Target:
Factor VIII|||Others
T77457
* VAT and and shipping costs not included. Errors and price changes excepted